Minh Anh Huynh

Minh Anh Huynh

Auto-generated profile, based on publicly available information

Minh Anh Huynh

Queensland Quantum and Advanced Technologies Research Institute (QUATRI) Griffith University Nathan Queensland Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
TNThi Thanh-Ha Nguyen
Thi Thanh-Ha Nguyen
CNCong Minh Nguyen
Cong Minh Nguyen
MHMinh Anh Huynh
Minh Anh Huynh
HVHoang Huy Vu
Hoang Huy Vu
TNTuan-Khoa Nguyen
Tuan-Khoa Nguyen
Nam-Trung NguyenNam-Trung Nguyen
Nam-Trung Nguyen
The rapid advancement of wearable biosensors has revolutionized healthcare monitoring by screening in a non-invasive and continuous manner. Among various sensing techniques, field-effect transistor (FET)-based wearable biosensors attract increasing attention due to their advantages such as label-free detection, fast response, easy operation, and capability of integration. This review explores the innovative developments and applications of FET-based wearable biosensors for healthcare monitoring. Beginning with an introduction to the significance of wearable biosensors, the paper gives an overview of structural and operational principles of FETs, providing insights into their diverse classifications. Next, the paper discusses the fabrication methods, semiconductor surface modification techniques and gate surface functionalization strategies. This background lays the foundation for exploring specific FET-based biosensor designs, including enzyme, antibody and nanobody, aptamer, as well as ion-sensitive membrane sensors. Subsequently, the paper investigates the incorporation of FET-based biosensors in monitoring biomarkers present in physiological fluids such as sweat, tears, saliva, and skin interstitial fluid (ISF). Finally, we address challenges, technical issues, and opportunities related to FET-based biosensor applications. This comprehensive review underscores the transformative potential of FET-based wearable biosensors in healthcare monitoring. By offering a multidimensional perspective on device design, fabrication, functionalization and applications, this paper aims to serve as a valuable resource for researchers in the field of biosensing technology and personalized healthcare.

26 May 2026 in Advanced Materials Technologies
Verified
Journal Article
Open access
MHMinh Anh Huynh
Minh Anh Huynh
MBMatthew Barton
Matthew Barton
SYSharda Yadav
Sharda Yadav
TNTuan‐Khoa Nguyen
Tuan‐Khoa Nguyen
Nam-Trung NguyenNam-Trung Nguyen
Nam-Trung Nguyen
Cancer incidence continues to rise globally, highlighting an urgent need for advanced bioelectronic technologies capable of simultaneous cellular monitoring and highly localized therapeutic intervention. In this work, we present a flexible implantable silicon carbide (SiC) multi‐electrode array (MEA) designed for multichannel electrophysiological recording and targeted irreversible electroporation (IRE)‐based cancer cell ablation. Leveraging the wide‐bandgap properties, chemical inertness, mechanical robustness, and proven biocompatibility of SiC, the proposed MEA provides a durable and reliable platform for long‐term operation under physiological conditions. Electrical characterization demonstrates excellent signal fidelity, with near‐unity transmission efficiency and minimal signal distortion maintained across frequencies from 0.1 to 100 Hz, even after 2000 bending cycles. In vitro experiments show that the SiC MEA enables stable, simultaneous multichannel recording of MDA‐MB‐231 breast cancer cells, capturing enhanced current fluctuations associated with cellular attachment and metabolic activity. Furthermore, the device successfully induces localized IRE, leading to effective cancer cell ablation without reliance on thermal mechanisms. In vivo implantation studies confirm favorable biocompatibility, with no significant inflammation, fibrosis, or adverse tissue responses observed. Collectively, these results establish flexible SiC‐based MEAs as a platform for precision‐targeted cancer treatment and monitoring.

10 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
TNThi Thanh Ha Nguyen
Thi Thanh Ha Nguyen
MHMinh Anh Huynh
Minh Anh Huynh
CNCong Minh Nguyen
Cong Minh Nguyen
QTQuang Thang Trinh
Quang Thang Trinh
CPCo D. Pham
Co D. Pham
Nam-Trung NguyenNam-Trung Nguyen
Nam-Trung Nguyen
Early and accurate monitoring of neurotransmitters, particularly serotonin and dopamine is essential for understanding neurological function and enabling timely diagnosis of related disorders such as depression, Parkinson’s disease, and schizophrenia. Although field-effect transistor (FET) biosensors have shown significant potential to address this need,achieving long-term stability and multiplexed detection in complex biological environments remains challenging. Here, we present a silicon carbide (SiC) - based extended-gate field-effect transistor (EG-FET) biosensor capable of multiplexed detection of serotonin, dopamine, and pH. The device is built on single-crystalline 3C-SiC thin film epitaxially grown on Si(100), utilising exceptional chemical inertness, electrochemical robustness and mechanical durability. These properties enable low leakage currents, low background noise, and stable operation in complex electrolytes. Functionalising SiC sensing surface with aptamer allows for selective binding and detection within a dynamic range of 1 pM–1 µM, achieving a detection limit of 1 pM for both serotonin and dopamine, as well as a pH sensitivity of 47.4 mV/pH. Surface modification was validated using X-ray photoelectron spectroscopy (XPS) and water contact angle (WCA) measurements, while density functional theory simulations revealed conformational rearrangements and charge redistribution upon aptamer–analyte interaction. These results demonstrate the strong potential of SiC-based EG-FET as robust, multiplexed biosensing platforms for neurotransmitter monitoring and future point-of-care (PoC) diagnostic applications.

22 July 2026 in Advanced Materials Interfaces
Verified
Journal Article
Open access
PDF file
MHMinh Anh Huynh
Minh Anh Huynh
SYSharda Yadav
Sharda Yadav
TNTuan‐Khoa Nguyen
Tuan‐Khoa Nguyen
Nam-Trung NguyenNam-Trung Nguyen
Nam-Trung Nguyen
Flexible bioelectronic interfaces are transforming biomedical engineering by integrating electronic systems with soft biological tissues for in situ cell sensing and targeted therapy. Wide‐bandgap semiconductors have emerged as promising materials due to their inherent biocompatibility, mechanical robustness, and stable semiconducting properties. We recently grew thin single‐crystalline silicon carbide, a promising wide‐bandgap material for bioelectronics, on silicon substrates. Nano‐thin silicon carbide brings exciting new prospects to precise in‐body therapeutics. However, the degradation of materials working in relatively corrosive environments of biofluids, especially with the application of electrical currents, presents a major challenge. In this study, we demonstrate the design, wafer‐scale microfabrication process, and evaluation of a flexible cubic silicon carbide (3C‐SiC) electrode system for cellular bioelectrical sensing and irreversible electroporation ablation of cancer cells. The electrode system exhibits excellent electrochemical stability and mechanical compliance in physiological environments, ensuring conformal contact with soft tissue. Electroporation procedures on MDA‐MB‐231 breast cancer cells demonstrated highly efficient cell lysis after a short application of monophasic current. Concurrently, the electrodes supported robust real‐time recording of cellular activity, confirming their capability for sensing‐and‐actuation integration. Our results indicate a promising potential of wide‐bandgap semiconductors for robust and multifunctional bioelectronic interfaces toward targeted theragnostic at cellular levels.